NeuroScientific Biopharmaceuticals Limited engages in the research and development of biomedical products targeting neurodegenerative conditions. Its lead product is the EmtinB drug for the treatment of optic nerve diseases, such as glaucoma. The company also develops StemSmart platform technology to treat inflammatory immune disorders. NeuroScientific Biopharmaceuticals Limited was incorporated in 2002 and is based in Perth, Australia.
Show more...
FAQ
Neuroscientific Biopharmaceuticals 今天的股價是多少?▼
NSB.AU 目前價格為 A$0.11 AUD,過去 24 小時下跌了 -4.55%。在圖表上更密切關注 Neuroscientific Biopharmaceuticals 股票的表現。
Neuroscientific Biopharmaceuticals 的股票代號是什麼?▼
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Neuroscientific Biopharmaceuticals 的股票以代號 NSB.AU 進行交易。
Neuroscientific Biopharmaceuticals 的股價在上漲嗎?▼
NSB.AU 股票較上週上漲 +0%,本月上漲 +5%,過去一年 Neuroscientific Biopharmaceuticals 上漲 +114.29%。
Neuroscientific Biopharmaceuticals 的市值是多少?▼
今天 Neuroscientific Biopharmaceuticals 的市值為 34.92M
Neuroscientific Biopharmaceuticals 去年的營收是多少?▼
Neuroscientific Biopharmaceuticals 去年的營收為 0AUD。
Neuroscientific Biopharmaceuticals 去年的淨利是多少?▼
NSB.AU 去年的淨收益為 -3.69MAUD。
Neuroscientific Biopharmaceuticals 位於哪個產業?▼
Neuroscientific Biopharmaceuticals從事於Health & Wellness產業。
Neuroscientific Biopharmaceuticals 何時完成拆股?▼
Neuroscientific Biopharmaceuticals 最近沒有進行任何拆股。
Neuroscientific Biopharmaceuticals 的總部在哪裡?▼
Neuroscientific Biopharmaceuticals 的總部位於 澳洲 的 Perth。